Clinical Trial Update: Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD [Phase 3]

View source ↗

Summary

Phase 3 trial of buagafuran capsules for generalized anxiety disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Buagafuran capsules (Buagafuran)

Snippet

Sponsor: Beijing Union Pharmaceutical Factory Ltd | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: RECRUITING